Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 63fludarabine phosphate 52Busulfan 48Cyclosporine 37Antilymphocyte Serum 36Peripheral Blood Stem Cell Transplantation 35Cytarabine 29Filgrastim 28Mycophenolic Acid 27Whole-Body Irradiation 26Radiotherapy 26Melphalan 26Cord Blood Stem Cell Transplantation 24Tacrolimus 23Methotrexate 23Methylprednisolone 21fludarabine 19Etoposide 16Thiotepa 11Granulocyte Colony-Stimulating Factor 11Azacitidine 10Alemtuzumab 9Daunorubicin 8sargramostim 7Idarubicin 7Decitabine 7Biopsy 7Topotecan 6Stem Cell Transplantation 6Mitoxantrone 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic Syndromes × zosuquidar trihydrochloride × Classical hematology × Clear all
NCT00046930 2023-07-05

Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia

Eastern Cooperative Oncology Group

Phase 3 Completed
449 enrolled 9 charts
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡